Related Experiment Video

Updated: Aug 8, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

[Viral therapy of cancer]

K Suzuki1, D T Curiel

  • 1Gene Therapy Center, University of Alabama at Birmingham, AL, USA. kaori.suzuki@ccc.uab.edu

Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion
|October 16, 2001
PubMed

Insights

Oncolytic viruses offer a promising cancer therapy alternative, overcoming conventional treatment limitations. Advances in virology enable engineered viruses for targeted tumor replication, showing safety and efficacy in clinical trials.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Context:

  • Conventional cancer therapies face challenges including toxicity and limited efficacy in advanced stages.
  • Gene therapy shows promise but struggles with transduction efficiency.
  • Oncolytic viruses are emerging as a viable alternative for cancer treatment.

Purpose:

  • To review the biological mechanisms of oncolytic virus therapy.
  • To discuss the challenges and limitations associated with this therapeutic approach.
  • To summarize the current status of ongoing clinical trials for oncolytic virotherapy.

Summary:

  • Oncolytic viruses are engineered to selectively replicate within tumor cells, leading to cancer cell destruction.
  • Adenovirus and herpes simplex type 1 mutants are prominent examples currently used in clinical studies.
  • Recent trials demonstrate the safety and efficacy of these viruses, with potential for combination therapies.

Impact:

  • Oncolytic virus therapy presents a novel strategy with improved tumor specificity and reduced normal tissue toxicity.
  • Successful clinical trials indicate a potential paradigm shift in cancer treatment modalities.
  • Combination of oncolytic virotherapy with chemotherapy or radiotherapy shows additive antineoplastic effects, enhancing treatment outcomes.

More Related Videos

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...